Merck boosts cancer pipeline in €464m deal
Merck & Co has announced it will acquire immunotherapy-focused Rigontec and lead candidate RGT100, designed to treat patients with solid tumours and lymphoma.
Archives for September 7, 2017
Lilly preserves biomanfacturing network amid $500m cost-saving restructure
Eli Lilly has announced a restructuring plan which will cut around 3,500 jobs but biomanufacturing will remain largely unaffected.
CGT Catapult teams with TrakCel for cell and gene therapy tracking
Firms that make therapies at the Cell and Gene Therapy Catapult facility in Stevenage, UK will track their products using tech provided by TrakCel.